Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion type Assertion NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_head.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion description "[Mutations in P53 were identified in 25 of 237 tumors (10.5%), which included 1 of 45 small lymphocytic lymphomas (SLLs), 2 of 38 follicular small cleaved-cell lymphomas (FSCCs), 2 of 35 follicular mixed small cleaved-cell and large-cell lymphomas (FMxs), 1 of 4 follicular large-cell lymphomas (FLCs), 1 of 14 diffuse small cleaved-cell lymphomas (DSCCs), 2 of 17 diffuse mixed small- and large-cell lymphomas (DMxs), and 16 of 84 diffuse large-cell lymphomas (DLCCs); the difference between the histologic groups was significant (P < .01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_provenance.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion evidence source_evidence_literature NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_provenance.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion SIO_000772 9354678 NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_provenance.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion wasDerivedFrom befree-2016 NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_provenance.
- NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_assertion wasGeneratedBy ECO_0000203 NP1383157.RAUyaToBMVRvc55_0DbD4q-vNae-iVnyW7f6uBPb_IziI130_provenance.